Literature DB >> 2022410

Relation of obesity and diet to sympathetic nervous system activity.

R J Troisi1, S T Weiss, D R Parker, D Sparrow, J B Young, L Landsberg.   

Abstract

The hypothesis that dietary intake and obesity stimulate the sympathetic nervous system was investigated in a cross-sectional study of 572 men aged 43-85 years from the Normative Aging Study. Habitus was represented by body mass index, as a measure of overall adiposity, and by the ratio of abdomen-to-hip circumference (abdomen/hip ratio), as a measure of centripetal fat distribution. Sympathetic activity was assessed by measurement of 24-hour urinary norepinephrine excretion. Increased body mass index and total caloric intake were independently associated with increased 24-hour urinary norepinephrine excretion (p = 0.0001 and p = 0.0055, respectively). In addition, mean urinary norepinephrine excretion was higher in subjects classified as either hyperglycemic (serum fasting glucose greater than or equal to 113 mg/dl) and hyperinsulinemic (serum fasting insulin greater than or equal to 19 microIU/ml) (p = 0.0023) or in subjects classified as either hyperglycemic or hyperinsulinemic (p = 0.0063) than the mean urinary norepinephrine excretion in normal subjects. These relations were demonstrated to be independent of age, smoking status, and physical activity. Our results are consistent with the hypothesis that insulin mediates sympathetic stimulation in response to dietary intake and increases sympathetic nervous system activity in the obese.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022410     DOI: 10.1161/01.hyp.17.5.669

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

Review 1.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Obesity and catecholamine responses to maximal exercise in adolescent girls.

Authors:  H Zouhal; G Jabbour; H Youssef; A Flaa; E Moussa; C Groussard; C Jacob
Journal:  Eur J Appl Physiol       Date:  2010-05-08       Impact factor: 3.078

Review 3.  Cardiovascular risks in obesity.

Authors:  E C Uchegbu; P G Kopelman
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 4.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

5.  Insulin resistance and the metabolic syndrome.

Authors:  L Landsberg
Journal:  Diabetologia       Date:  2005-07       Impact factor: 10.122

6.  Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.

Authors:  P T Sawicki; L Heinemann; A Starke; M Berger
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

Review 7.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

Review 8.  Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.

Authors:  Jonathan G Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

Review 9.  Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence.

Authors:  Tim Hollstein; Paolo Piaggi
Journal:  Curr Obes Rep       Date:  2020-06

Review 10.  Catecholamines and obesity: effects of exercise and training.

Authors:  Hassane Zouhal; Sophie Lemoine-Morel; Marie-Eve Mathieu; Gretchen A Casazza; Georges Jabbour
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.